Antibacterial and immunogenic behavior of silver coatings on additively manufactured porous titanium

[Display omitted] Implant-associated infections (IAI) are often recurrent, expensive to treat, and associated with high rates of morbidity, if not mortality. We biofunctionalized the surface of additively manufactured volume-porous titanium implants using electrophoretic deposition (EPD) as a way to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta biomaterialia 2018-11, Vol.81, p.315-327
Hauptverfasser: Croes, M., Bakhshandeh, S., van Hengel, I.A.J., Lietaert, K., van Kessel, K.P.M., Pouran, B., van der Wal, B.C.H., Vogely, H.C., Van Hecke, W., Fluit, A.C., Boel, C.H.E., Alblas, J., Zadpoor, A.A., Weinans, H., Amin Yavari, S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 327
container_issue
container_start_page 315
container_title Acta biomaterialia
container_volume 81
creator Croes, M.
Bakhshandeh, S.
van Hengel, I.A.J.
Lietaert, K.
van Kessel, K.P.M.
Pouran, B.
van der Wal, B.C.H.
Vogely, H.C.
Van Hecke, W.
Fluit, A.C.
Boel, C.H.E.
Alblas, J.
Zadpoor, A.A.
Weinans, H.
Amin Yavari, S.
description [Display omitted] Implant-associated infections (IAI) are often recurrent, expensive to treat, and associated with high rates of morbidity, if not mortality. We biofunctionalized the surface of additively manufactured volume-porous titanium implants using electrophoretic deposition (EPD) as a way to eliminate the peri-operative bacterial load and prevent IAI. Chitosan-based (Ch) coatings were incorporated with different concentrations of silver (Ag) nanoparticles or vancomycin. A full-scale in vitro and in vivo study was then performed to evaluate the antibacterial, immunogenic, and osteogenic activity of the developed implants. In vitro, Ch + vancomycin or Ch + Ag coatings completely eliminated, or reduced the number of planktonic and adherent Staphylococcus aureus by up to 4 orders of magnitude, respectively. In an in vivo tibia intramedullary implant model, Ch + Ag coatings caused no adverse immune or bone response under aseptic conditions. Following Staphylococcus aureus inoculation, Ch + vancomycin coatings reduced the implant infection rate as compared to chitosan-only coatings. Ch + Ag implants did not demonstrate antibacterial effects in vivo and even aggravated infection-mediated bone remodeling including increased osteoclast formation and inflammation-induced new bone formation. As an explanation for the poor antibacterial activity of Ch + Ag implants, it was found that antibacterial Ag concentrations were cytotoxic for neutrophils, and that non-toxic Ag concentrations diminished their phagocytic activity. This study shows the potential of EPD coating to biofunctionalize porous titanium implants with different antibacterial agents. Using this method, Ag-based coatings seem inferior to antibiotic coatings, as their adverse effects on the normal immune response could cancel the direct antibacterial effects of Ag nanoparticles. Implant-associated infections (IAI) are a clinical, societal, and economical burden. Surface biofunctionalization approaches can render complex metal implants with strong local antibacterial action. The antibacterial effects of inorganic materials such as silver nanoparticles (Ag NPs) are often highlighted under very confined conditions in vitro. As a novelty, this study also reports the antibacterial, immunogenic, and osteogenic activity of Ag NP-coated additively-manufactured titanium in vivo. Importantly, it was found that the developed coatings could impair the normal function of neutrophils, the most important phagocytic
doi_str_mv 10.1016/j.actbio.2018.09.051
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2115280564</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1742706118305804</els_id><sourcerecordid>2115280564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-d6b8c2d8e9aa20d945940bdd2101bb641f71fa97197f445ce32ac0644ddfd5593</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0EoqXwBghZYsMmwXbsxN4gVRV_UiU2sLYce1LmKrEvtnOlvj2ubmHBgtXM4pszM-cQ8pqznjM-vj_0ztcZUy8Y1z0zPVP8CbnketLdpEb9tPWTFN3ERn5BXpRyYGzQXOjn5GJgYtSGT5ckXMeKc1OCjG6lLgaK27bHdAcRPZ3hpzthyjQttOB6gkx9chXjXaEpUhcCVjzBek83F_el6ewZAj2mnPZCK1YXcd9ekmeLWwu8eqxX5Menj99vvnS33z5_vbm-7fxgWO3COGsvggbjnGDBSGUkm0MQ7d95HiVfJr44M3EzLVIqD4Nwno1ShrAEpcxwRd6ddY85_dqhVLth8bCuLkK7xwrOldBMjbKhb_9BD2nPsV3XKKV0c46JRskz5XMqJcNijxk3l-8tZ_YhBXuw5xTsQwqWGdtSaGNvHsX3eYPwd-iP7Q34cAaguXFCyLZ4hOghYAZfbUj4_w2_AcCAm7I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2155874202</pqid></control><display><type>article</type><title>Antibacterial and immunogenic behavior of silver coatings on additively manufactured porous titanium</title><source>Elsevier ScienceDirect Journals</source><creator>Croes, M. ; Bakhshandeh, S. ; van Hengel, I.A.J. ; Lietaert, K. ; van Kessel, K.P.M. ; Pouran, B. ; van der Wal, B.C.H. ; Vogely, H.C. ; Van Hecke, W. ; Fluit, A.C. ; Boel, C.H.E. ; Alblas, J. ; Zadpoor, A.A. ; Weinans, H. ; Amin Yavari, S.</creator><creatorcontrib>Croes, M. ; Bakhshandeh, S. ; van Hengel, I.A.J. ; Lietaert, K. ; van Kessel, K.P.M. ; Pouran, B. ; van der Wal, B.C.H. ; Vogely, H.C. ; Van Hecke, W. ; Fluit, A.C. ; Boel, C.H.E. ; Alblas, J. ; Zadpoor, A.A. ; Weinans, H. ; Amin Yavari, S.</creatorcontrib><description>[Display omitted] Implant-associated infections (IAI) are often recurrent, expensive to treat, and associated with high rates of morbidity, if not mortality. We biofunctionalized the surface of additively manufactured volume-porous titanium implants using electrophoretic deposition (EPD) as a way to eliminate the peri-operative bacterial load and prevent IAI. Chitosan-based (Ch) coatings were incorporated with different concentrations of silver (Ag) nanoparticles or vancomycin. A full-scale in vitro and in vivo study was then performed to evaluate the antibacterial, immunogenic, and osteogenic activity of the developed implants. In vitro, Ch + vancomycin or Ch + Ag coatings completely eliminated, or reduced the number of planktonic and adherent Staphylococcus aureus by up to 4 orders of magnitude, respectively. In an in vivo tibia intramedullary implant model, Ch + Ag coatings caused no adverse immune or bone response under aseptic conditions. Following Staphylococcus aureus inoculation, Ch + vancomycin coatings reduced the implant infection rate as compared to chitosan-only coatings. Ch + Ag implants did not demonstrate antibacterial effects in vivo and even aggravated infection-mediated bone remodeling including increased osteoclast formation and inflammation-induced new bone formation. As an explanation for the poor antibacterial activity of Ch + Ag implants, it was found that antibacterial Ag concentrations were cytotoxic for neutrophils, and that non-toxic Ag concentrations diminished their phagocytic activity. This study shows the potential of EPD coating to biofunctionalize porous titanium implants with different antibacterial agents. Using this method, Ag-based coatings seem inferior to antibiotic coatings, as their adverse effects on the normal immune response could cancel the direct antibacterial effects of Ag nanoparticles. Implant-associated infections (IAI) are a clinical, societal, and economical burden. Surface biofunctionalization approaches can render complex metal implants with strong local antibacterial action. The antibacterial effects of inorganic materials such as silver nanoparticles (Ag NPs) are often highlighted under very confined conditions in vitro. As a novelty, this study also reports the antibacterial, immunogenic, and osteogenic activity of Ag NP-coated additively-manufactured titanium in vivo. Importantly, it was found that the developed coatings could impair the normal function of neutrophils, the most important phagocytic cells protecting us from IAI. Not surprisingly, the Ag NP-based coatings were outperformed by an antibiotic-based coating. This emphasizes the importance of also targeting implant immune-modulatory functions in future coating strategies against IAI.</description><identifier>ISSN: 1742-7061</identifier><identifier>EISSN: 1878-7568</identifier><identifier>DOI: 10.1016/j.actbio.2018.09.051</identifier><identifier>PMID: 30268917</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Additive manufacturing ; Anti-bacterial coatings ; Antibacterial activity ; Antibacterial agents ; Antibiotics ; Biocompatibility ; Biomedical materials ; Bone growth ; Bone morphology ; Bone remodeling ; Bones ; Chitosan ; Coating effects ; Coatings ; Cytotoxicity ; Drug resistance ; Electrophoretic deposition ; Hydrogels ; Immune response ; Immune system ; Immunogenicity ; In vivo methods and tests ; Infections ; Inoculation ; Leukocytes (neutrophilic) ; Morbidity ; Morphology ; Nanoparticles ; Osteogenesis ; Osteomyelitis ; Phagocytes ; Porous implants ; Rat tibia model ; Silver ; Staphylococcus aureus ; Surgical implants ; Tibia ; Titanium ; Vancomycin</subject><ispartof>Acta biomaterialia, 2018-11, Vol.81, p.315-327</ispartof><rights>2018 Acta Materialia Inc.</rights><rights>Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier BV Nov 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-d6b8c2d8e9aa20d945940bdd2101bb641f71fa97197f445ce32ac0644ddfd5593</citedby><cites>FETCH-LOGICAL-c390t-d6b8c2d8e9aa20d945940bdd2101bb641f71fa97197f445ce32ac0644ddfd5593</cites><orcidid>0000-0002-0270-8905</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1742706118305804$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30268917$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Croes, M.</creatorcontrib><creatorcontrib>Bakhshandeh, S.</creatorcontrib><creatorcontrib>van Hengel, I.A.J.</creatorcontrib><creatorcontrib>Lietaert, K.</creatorcontrib><creatorcontrib>van Kessel, K.P.M.</creatorcontrib><creatorcontrib>Pouran, B.</creatorcontrib><creatorcontrib>van der Wal, B.C.H.</creatorcontrib><creatorcontrib>Vogely, H.C.</creatorcontrib><creatorcontrib>Van Hecke, W.</creatorcontrib><creatorcontrib>Fluit, A.C.</creatorcontrib><creatorcontrib>Boel, C.H.E.</creatorcontrib><creatorcontrib>Alblas, J.</creatorcontrib><creatorcontrib>Zadpoor, A.A.</creatorcontrib><creatorcontrib>Weinans, H.</creatorcontrib><creatorcontrib>Amin Yavari, S.</creatorcontrib><title>Antibacterial and immunogenic behavior of silver coatings on additively manufactured porous titanium</title><title>Acta biomaterialia</title><addtitle>Acta Biomater</addtitle><description>[Display omitted] Implant-associated infections (IAI) are often recurrent, expensive to treat, and associated with high rates of morbidity, if not mortality. We biofunctionalized the surface of additively manufactured volume-porous titanium implants using electrophoretic deposition (EPD) as a way to eliminate the peri-operative bacterial load and prevent IAI. Chitosan-based (Ch) coatings were incorporated with different concentrations of silver (Ag) nanoparticles or vancomycin. A full-scale in vitro and in vivo study was then performed to evaluate the antibacterial, immunogenic, and osteogenic activity of the developed implants. In vitro, Ch + vancomycin or Ch + Ag coatings completely eliminated, or reduced the number of planktonic and adherent Staphylococcus aureus by up to 4 orders of magnitude, respectively. In an in vivo tibia intramedullary implant model, Ch + Ag coatings caused no adverse immune or bone response under aseptic conditions. Following Staphylococcus aureus inoculation, Ch + vancomycin coatings reduced the implant infection rate as compared to chitosan-only coatings. Ch + Ag implants did not demonstrate antibacterial effects in vivo and even aggravated infection-mediated bone remodeling including increased osteoclast formation and inflammation-induced new bone formation. As an explanation for the poor antibacterial activity of Ch + Ag implants, it was found that antibacterial Ag concentrations were cytotoxic for neutrophils, and that non-toxic Ag concentrations diminished their phagocytic activity. This study shows the potential of EPD coating to biofunctionalize porous titanium implants with different antibacterial agents. Using this method, Ag-based coatings seem inferior to antibiotic coatings, as their adverse effects on the normal immune response could cancel the direct antibacterial effects of Ag nanoparticles. Implant-associated infections (IAI) are a clinical, societal, and economical burden. Surface biofunctionalization approaches can render complex metal implants with strong local antibacterial action. The antibacterial effects of inorganic materials such as silver nanoparticles (Ag NPs) are often highlighted under very confined conditions in vitro. As a novelty, this study also reports the antibacterial, immunogenic, and osteogenic activity of Ag NP-coated additively-manufactured titanium in vivo. Importantly, it was found that the developed coatings could impair the normal function of neutrophils, the most important phagocytic cells protecting us from IAI. Not surprisingly, the Ag NP-based coatings were outperformed by an antibiotic-based coating. This emphasizes the importance of also targeting implant immune-modulatory functions in future coating strategies against IAI.</description><subject>Additive manufacturing</subject><subject>Anti-bacterial coatings</subject><subject>Antibacterial activity</subject><subject>Antibacterial agents</subject><subject>Antibiotics</subject><subject>Biocompatibility</subject><subject>Biomedical materials</subject><subject>Bone growth</subject><subject>Bone morphology</subject><subject>Bone remodeling</subject><subject>Bones</subject><subject>Chitosan</subject><subject>Coating effects</subject><subject>Coatings</subject><subject>Cytotoxicity</subject><subject>Drug resistance</subject><subject>Electrophoretic deposition</subject><subject>Hydrogels</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunogenicity</subject><subject>In vivo methods and tests</subject><subject>Infections</subject><subject>Inoculation</subject><subject>Leukocytes (neutrophilic)</subject><subject>Morbidity</subject><subject>Morphology</subject><subject>Nanoparticles</subject><subject>Osteogenesis</subject><subject>Osteomyelitis</subject><subject>Phagocytes</subject><subject>Porous implants</subject><subject>Rat tibia model</subject><subject>Silver</subject><subject>Staphylococcus aureus</subject><subject>Surgical implants</subject><subject>Tibia</subject><subject>Titanium</subject><subject>Vancomycin</subject><issn>1742-7061</issn><issn>1878-7568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1TAQhS0EoqXwBghZYsMmwXbsxN4gVRV_UiU2sLYce1LmKrEvtnOlvj2ubmHBgtXM4pszM-cQ8pqznjM-vj_0ztcZUy8Y1z0zPVP8CbnketLdpEb9tPWTFN3ERn5BXpRyYGzQXOjn5GJgYtSGT5ckXMeKc1OCjG6lLgaK27bHdAcRPZ3hpzthyjQttOB6gkx9chXjXaEpUhcCVjzBek83F_el6ewZAj2mnPZCK1YXcd9ekmeLWwu8eqxX5Menj99vvnS33z5_vbm-7fxgWO3COGsvggbjnGDBSGUkm0MQ7d95HiVfJr44M3EzLVIqD4Nwno1ShrAEpcxwRd6ddY85_dqhVLth8bCuLkK7xwrOldBMjbKhb_9BD2nPsV3XKKV0c46JRskz5XMqJcNijxk3l-8tZ_YhBXuw5xTsQwqWGdtSaGNvHsX3eYPwd-iP7Q34cAaguXFCyLZ4hOghYAZfbUj4_w2_AcCAm7I</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Croes, M.</creator><creator>Bakhshandeh, S.</creator><creator>van Hengel, I.A.J.</creator><creator>Lietaert, K.</creator><creator>van Kessel, K.P.M.</creator><creator>Pouran, B.</creator><creator>van der Wal, B.C.H.</creator><creator>Vogely, H.C.</creator><creator>Van Hecke, W.</creator><creator>Fluit, A.C.</creator><creator>Boel, C.H.E.</creator><creator>Alblas, J.</creator><creator>Zadpoor, A.A.</creator><creator>Weinans, H.</creator><creator>Amin Yavari, S.</creator><general>Elsevier Ltd</general><general>Elsevier BV</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0270-8905</orcidid></search><sort><creationdate>201811</creationdate><title>Antibacterial and immunogenic behavior of silver coatings on additively manufactured porous titanium</title><author>Croes, M. ; Bakhshandeh, S. ; van Hengel, I.A.J. ; Lietaert, K. ; van Kessel, K.P.M. ; Pouran, B. ; van der Wal, B.C.H. ; Vogely, H.C. ; Van Hecke, W. ; Fluit, A.C. ; Boel, C.H.E. ; Alblas, J. ; Zadpoor, A.A. ; Weinans, H. ; Amin Yavari, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-d6b8c2d8e9aa20d945940bdd2101bb641f71fa97197f445ce32ac0644ddfd5593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Additive manufacturing</topic><topic>Anti-bacterial coatings</topic><topic>Antibacterial activity</topic><topic>Antibacterial agents</topic><topic>Antibiotics</topic><topic>Biocompatibility</topic><topic>Biomedical materials</topic><topic>Bone growth</topic><topic>Bone morphology</topic><topic>Bone remodeling</topic><topic>Bones</topic><topic>Chitosan</topic><topic>Coating effects</topic><topic>Coatings</topic><topic>Cytotoxicity</topic><topic>Drug resistance</topic><topic>Electrophoretic deposition</topic><topic>Hydrogels</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunogenicity</topic><topic>In vivo methods and tests</topic><topic>Infections</topic><topic>Inoculation</topic><topic>Leukocytes (neutrophilic)</topic><topic>Morbidity</topic><topic>Morphology</topic><topic>Nanoparticles</topic><topic>Osteogenesis</topic><topic>Osteomyelitis</topic><topic>Phagocytes</topic><topic>Porous implants</topic><topic>Rat tibia model</topic><topic>Silver</topic><topic>Staphylococcus aureus</topic><topic>Surgical implants</topic><topic>Tibia</topic><topic>Titanium</topic><topic>Vancomycin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Croes, M.</creatorcontrib><creatorcontrib>Bakhshandeh, S.</creatorcontrib><creatorcontrib>van Hengel, I.A.J.</creatorcontrib><creatorcontrib>Lietaert, K.</creatorcontrib><creatorcontrib>van Kessel, K.P.M.</creatorcontrib><creatorcontrib>Pouran, B.</creatorcontrib><creatorcontrib>van der Wal, B.C.H.</creatorcontrib><creatorcontrib>Vogely, H.C.</creatorcontrib><creatorcontrib>Van Hecke, W.</creatorcontrib><creatorcontrib>Fluit, A.C.</creatorcontrib><creatorcontrib>Boel, C.H.E.</creatorcontrib><creatorcontrib>Alblas, J.</creatorcontrib><creatorcontrib>Zadpoor, A.A.</creatorcontrib><creatorcontrib>Weinans, H.</creatorcontrib><creatorcontrib>Amin Yavari, S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Acta biomaterialia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Croes, M.</au><au>Bakhshandeh, S.</au><au>van Hengel, I.A.J.</au><au>Lietaert, K.</au><au>van Kessel, K.P.M.</au><au>Pouran, B.</au><au>van der Wal, B.C.H.</au><au>Vogely, H.C.</au><au>Van Hecke, W.</au><au>Fluit, A.C.</au><au>Boel, C.H.E.</au><au>Alblas, J.</au><au>Zadpoor, A.A.</au><au>Weinans, H.</au><au>Amin Yavari, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibacterial and immunogenic behavior of silver coatings on additively manufactured porous titanium</atitle><jtitle>Acta biomaterialia</jtitle><addtitle>Acta Biomater</addtitle><date>2018-11</date><risdate>2018</risdate><volume>81</volume><spage>315</spage><epage>327</epage><pages>315-327</pages><issn>1742-7061</issn><eissn>1878-7568</eissn><abstract>[Display omitted] Implant-associated infections (IAI) are often recurrent, expensive to treat, and associated with high rates of morbidity, if not mortality. We biofunctionalized the surface of additively manufactured volume-porous titanium implants using electrophoretic deposition (EPD) as a way to eliminate the peri-operative bacterial load and prevent IAI. Chitosan-based (Ch) coatings were incorporated with different concentrations of silver (Ag) nanoparticles or vancomycin. A full-scale in vitro and in vivo study was then performed to evaluate the antibacterial, immunogenic, and osteogenic activity of the developed implants. In vitro, Ch + vancomycin or Ch + Ag coatings completely eliminated, or reduced the number of planktonic and adherent Staphylococcus aureus by up to 4 orders of magnitude, respectively. In an in vivo tibia intramedullary implant model, Ch + Ag coatings caused no adverse immune or bone response under aseptic conditions. Following Staphylococcus aureus inoculation, Ch + vancomycin coatings reduced the implant infection rate as compared to chitosan-only coatings. Ch + Ag implants did not demonstrate antibacterial effects in vivo and even aggravated infection-mediated bone remodeling including increased osteoclast formation and inflammation-induced new bone formation. As an explanation for the poor antibacterial activity of Ch + Ag implants, it was found that antibacterial Ag concentrations were cytotoxic for neutrophils, and that non-toxic Ag concentrations diminished their phagocytic activity. This study shows the potential of EPD coating to biofunctionalize porous titanium implants with different antibacterial agents. Using this method, Ag-based coatings seem inferior to antibiotic coatings, as their adverse effects on the normal immune response could cancel the direct antibacterial effects of Ag nanoparticles. Implant-associated infections (IAI) are a clinical, societal, and economical burden. Surface biofunctionalization approaches can render complex metal implants with strong local antibacterial action. The antibacterial effects of inorganic materials such as silver nanoparticles (Ag NPs) are often highlighted under very confined conditions in vitro. As a novelty, this study also reports the antibacterial, immunogenic, and osteogenic activity of Ag NP-coated additively-manufactured titanium in vivo. Importantly, it was found that the developed coatings could impair the normal function of neutrophils, the most important phagocytic cells protecting us from IAI. Not surprisingly, the Ag NP-based coatings were outperformed by an antibiotic-based coating. This emphasizes the importance of also targeting implant immune-modulatory functions in future coating strategies against IAI.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30268917</pmid><doi>10.1016/j.actbio.2018.09.051</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-0270-8905</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1742-7061
ispartof Acta biomaterialia, 2018-11, Vol.81, p.315-327
issn 1742-7061
1878-7568
language eng
recordid cdi_proquest_miscellaneous_2115280564
source Elsevier ScienceDirect Journals
subjects Additive manufacturing
Anti-bacterial coatings
Antibacterial activity
Antibacterial agents
Antibiotics
Biocompatibility
Biomedical materials
Bone growth
Bone morphology
Bone remodeling
Bones
Chitosan
Coating effects
Coatings
Cytotoxicity
Drug resistance
Electrophoretic deposition
Hydrogels
Immune response
Immune system
Immunogenicity
In vivo methods and tests
Infections
Inoculation
Leukocytes (neutrophilic)
Morbidity
Morphology
Nanoparticles
Osteogenesis
Osteomyelitis
Phagocytes
Porous implants
Rat tibia model
Silver
Staphylococcus aureus
Surgical implants
Tibia
Titanium
Vancomycin
title Antibacterial and immunogenic behavior of silver coatings on additively manufactured porous titanium
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T14%3A34%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibacterial%20and%20immunogenic%20behavior%20of%20silver%20coatings%20on%20additively%20manufactured%20porous%20titanium&rft.jtitle=Acta%20biomaterialia&rft.au=Croes,%20M.&rft.date=2018-11&rft.volume=81&rft.spage=315&rft.epage=327&rft.pages=315-327&rft.issn=1742-7061&rft.eissn=1878-7568&rft_id=info:doi/10.1016/j.actbio.2018.09.051&rft_dat=%3Cproquest_cross%3E2115280564%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2155874202&rft_id=info:pmid/30268917&rft_els_id=S1742706118305804&rfr_iscdi=true